Healthcare Business

Becton, Dickinson is officially throwing its hat in the ring to fight COVID-19. Specifically, this firm is working on the front end by testing for the disease and antibodies that have been built up...
Chris Lange
InflaRx shares jumped early on Wednesday after the company announced that it has enrolled its first patient into a clinical trial for the treatment of severe COVID-19-induced pneumonia.
Chris Lange
Until late Monday, Amarin continued to get good news relevant to Vascepa, its treatment for cardiovascular disease. The big news, though, was lurking in Nevada federal district court.
Paul Ausick
Co-Diagnostics is on many shortlists of companies with partial medical solutions to slow the coronavirus outbreak. Investors have been on a roller-coaster ride. Is the stock ready to run?
Douglas A. McIntyre
Trinity Biotech released its fiscal fourth-quarter financial results on Tuesday morning, but that wasn’t what propelled the stock afterward.
Chris Lange
Vivus shares absolutely exploded on Tuesday after the company announced that it was accelerating the launch of telemedicine and remote monitoring modules.
Chris Lange
Some investors are looking for conservative growth ideas, and big pharma may be the ticket. These four top stocks have been hit hard, and the companies have paid dependable dividends for years.
Lee Jackson
There is plenty of competition among companies wanting to sell coronavirus test kits. Aytu Biosciences has placed a bet on its ability to help beat the coronavirus outbreak.
Paul Ausick
Bio-Path stock has taken a beating in the past five years. Investors obviously aren’t happy about this, and the way that management and the board of directors has handled it has been clumsy.
Chris Lange
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Chris Lange
Dynavax Technologies shares made a handy gain on Thursday after the company announced that it would be entering the coronavirus vaccine business. Is the market for these vaccines getting...
Chris Lange
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Chris Lange
SunTrust Robinson Humphrey has issued a new Buy rating Compugen, and the firm's target price represents more than 100% in implied upside from the prior close.
Jon C. Ogg
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine, treatment or test to deal with this coronavirus and here is where their stocks stand now.
Chris Lange
GenMark Diagnostics stock has really not made any of the zany exponential gains that have been seen in other coronavirus-related stocks.
Jon C. Ogg